|
|
|
08 November 2024
Timothy Lee, Senior Vice President of Legal and Public Affairs at the Center for Individual Freedom, discusses a to-do list that the Trump-Vance Administration should address upon entering office, including issues related to the border, inflation, tech policy, intellectual property protection, antitrust policy, and reducing the regulatory suffocation that has existed under the Biden-Harris Administration.
0:00
0:00
Related Podcasts
10 April 2026
Janatan Sayeh, Research Assistant at the Foundation for Defense of Democracies, discusses the state of the Iran war, its future trajectory and wider consequences, and what the two-week ceasefire means and what it may (or may not) accomplish.
14 February 2025
Tiger Joyce, President of the American Tort Reform Association, discusses the latest Judicial Hellholes report, the economic impact of lawsuit abuse, the ramifications of third-party litigation funding, and the looming legal battle over plastics.
07 October 2022
Ilya Shapiro, Director of Constitutional Studies at the Manhattan Institute, discusses what to look for in the new Supreme Court term that opened this week, most notably cases related to property rights, affirmative action, and immigration law, and insight into the recently filed case challenging President Biden’s student loan forgiveness plan.
12 May 2022
Nathan Lewis, author and a leading authority on monetary policy and economic history, discusses his latest book, Inflation: What It Is, Why It’s Bad, and How To Fix It, co-authored with Steve Forbes and Elizabeth Ames,. Lewis explains the threat inflation poses to our economy and democracy, what history has taught us about inflation, and guidelines to investing during inflationary times.
25 March 2022
Sally Pipes, President, CEO, and the Thomas W. Smith Fellow in Healthcare Policy at the Pacific Research Institute, discusses Senator Bernie Sanders' latest plan to invoke government red tape and strangle patient access, why both single-payer healthcare and the public option still won't work, how pharmaceutical price controls would limit access and stifle innovation, and why the FDA's accelerated approval program should continue, saving lives and money.
18 June 2021
Ilya Shapiro, Vice President of the Cato Institute and Director of the Robert A. Levy Center for Constitutional Studies, discusses the U.S. Supreme Court's current caseload compared to other years, increased unanimity on the Court, some of the biggest cases already decided and yet to be decided, and whether to expect a retirement announcement in the coming weeks.
